Veru (VERU) News Today → The only AI company to buy (From Porter & Company) (Ad) Free VERU Stock Alerts $1.00 -0.11 (-9.91%) (As of 05/29/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 27 at 5:55 PM | marketbeat.comAIGH Capital Management LLC Purchases New Stake in Veru Inc. (NASDAQ:VERU)AIGH Capital Management LLC purchased a new stake in Veru Inc. (NASDAQ:VERU - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 3,438,551 shares of the company's stock, valued at approximatelMay 26 at 6:54 AM | americanbankingnews.comMitchell Shuster Steiner Sells 63,379 Shares of Veru Inc. (NASDAQ:VERU) StockMay 25, 2024 | insidertrades.comInsider Selling: Veru Inc. (NASDAQ:VERU) CEO Sells 63,379 Shares of StockMay 24, 2024 | marketbeat.comVeru Inc. (NASDAQ:VERU) CEO Sells $77,956.17 in StockVeru Inc. (NASDAQ:VERU - Get Free Report) CEO Mitchell Shuster Steiner sold 63,379 shares of the firm's stock in a transaction on Friday, May 24th. The shares were sold at an average price of $1.23, for a total transaction of $77,956.17. Following the sale, the chief executive officer now directly owns 6,942,709 shares of the company's stock, valued at $8,539,532.07. The transaction was disclosed in a document filed with the SEC, which is available at this link.May 22, 2024 | finance.yahoo.comIndividual investors account for 48% of Veru Inc.'s (NASDAQ:VERU) ownership, while institutions account for 25%May 22, 2024 | globenewswire.comVeru to Present at the Jefferies Global Healthcare ConferenceMay 20, 2024 | marketbeat.comWorth Venture Partners LLC Invests $616,000 in Veru Inc. (NASDAQ:VERU)Worth Venture Partners LLC acquired a new position in shares of Veru Inc. (NASDAQ:VERU - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 855,855 shares of the company's stock, valued atMay 20, 2024 | americanbankingnews.comVeru Inc. (NASDAQ:VERU) CEO Mitchell Shuster Steiner Sells 28,066 SharesMay 19, 2024 | americanbankingnews.comMitchell Shuster Steiner Sells 84,021 Shares of Veru Inc. (NASDAQ:VERU) StockMay 18, 2024 | insidertrades.comMitchell Shuster Steiner Sells 28,066 Shares of Veru Inc. (NASDAQ:VERU) StockMay 17, 2024 | investing.comVeru Inc. CEO sells over $246k in company stockMay 17, 2024 | investing.comVeru Inc. executive buys $9,999 in company stockMay 16, 2024 | marketbeat.comEquities Analysts Issue Forecasts for Veru Inc.'s Q3 2024 Earnings (NASDAQ:VERU)Veru Inc. (NASDAQ:VERU - Free Report) - Investment analysts at B. Riley issued their Q3 2024 earnings per share estimates for Veru in a report issued on Monday, May 13th. B. Riley analyst W. Wood anticipates that the company will post earnings of ($0.05) per share for the quarter. B. Riley currenMay 15, 2024 | globenewswire.comVeru Announces Steven B. Heymsfield M.D.May 14, 2024 | globenewswire.comVeru Announces Mitchell Steiner as Keynote Speaker at Biomed Israel 2024: The 22nd National Life Science & Technology WeekMay 14, 2024 | marketbeat.comB. Riley Initiates Coverage on Veru (NASDAQ:VERU)B. Riley began coverage on Veru in a research note on Tuesday. They set a "buy" rating and a $5.00 target price on the stock.May 14, 2024 | markets.businessinsider.comBuy Rating for Veru Inc. on Promising Enobosarm Trials and Strategic Market PositioningMay 13, 2024 | marketbeat.comVeru's (VERU) Buy Rating Reiterated at HC WainwrightHC Wainwright reissued a "buy" rating and set a $3.00 price objective on shares of Veru in a report on Monday.May 10, 2024 | markets.businessinsider.comBuy Rating Affirmed on Veru Amid Strong Clinical Prospects and Solid Financial PositionMay 9, 2024 | finance.yahoo.comVeru Inc (VERU) Q2 2024 Earnings Call Transcript Highlights: Strategic Focus and Financial RecoveryMay 8, 2024 | msn.comVERU Stock Earnings: Veru Misses EPS, Beats Revenue for Q2 2024May 8, 2024 | finanznachrichten.deVeru Inc.: Veru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical ProgramMay 8, 2024 | finance.yahoo.comVeru Inc. (VERU) Fiscal 2024 Q2 Earnings: Clinical Advances Amid Financial StrainsMay 8, 2024 | globenewswire.comVeru Reports Fiscal 2024 Second Quarter Financial Results and Progress of its Enobosarm High Quality Weight Loss Clinical ProgramMay 7, 2024 | msn.comVeru Q2 2024 Earnings PreviewMay 6, 2024 | benzinga.comCritical Insights From Veru Analyst Ratings: What You Need To KnowMay 6, 2024 | marketbeat.comHC Wainwright Boosts Veru (NASDAQ:VERU) Price Target to $3.00HC Wainwright lifted their price target on Veru from $2.00 to $3.00 and gave the company a "buy" rating in a research report on Monday.May 3, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Veru (VERU) and GH Research (GHRS)May 2, 2024 | marketbeat.comVeru (VERU) to Release Quarterly Earnings on WednesdayVeru (NASDAQ:VERU) will be releasing earnings before the market opens on Wednesday, May 8, Zacks reports.May 2, 2024 | globenewswire.comVeru to Present at the GLP-1 Based Therapeutics SummitMay 1, 2024 | globenewswire.comVeru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024April 30, 2024 | globenewswire.comVeru Enrolls First Patients in Phase 2b Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight LossApril 30, 2024 | finance.yahoo.comPalisade Capital Management Welcomes Chris Mashia to Small Cap Core and Smid Cap Core Equity StrategiesApril 25, 2024 | globenewswire.comVeru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11April 19, 2024 | markets.businessinsider.comNetflix To Stop Sharing Subscriber Data; Stock DipsApril 15, 2024 | marketbeat.comVeru (NASDAQ:VERU) Earns "Outperform" Rating from OppenheimerOppenheimer reaffirmed an "outperform" rating and issued a $5.00 target price (down previously from $7.00) on shares of Veru in a report on Monday.April 1, 2024 | finance.yahoo.comVeru Announces Date of 2024 Annual Meeting of ShareholdersMarch 29, 2024 | morningstar.comVeru IncMarch 28, 2024 | marketbeat.comRaymond James Begins Coverage on Veru (NASDAQ:VERU)Raymond James initiated coverage on shares of Veru in a research note on Thursday. They set an "outperform" rating and a $3.00 target price for the company.March 22, 2024 | globenewswire.comVeru Reschedules Annual Meeting of ShareholdersMarch 21, 2024 | bizjournals.comWynwood offices targeted in $102M foreclosureMarch 19, 2024 | msn.comNaksha Saran plays a bike taxi driver in her next filmMarch 16, 2024 | ca.finance.yahoo.comVERU Mar 2024 0.500 putMarch 12, 2024 | globenewswire.comVeru Announces the Appointment of Louis Aronne MD as Chief Medical Advisor for its Enobosarm Program for High Quality Weight LossMarch 11, 2024 | finance.yahoo.comVERU Mar 2024 1.500 putMarch 9, 2024 | finance.yahoo.comVERU Jan 2025 17.000 callMarch 9, 2024 | finance.yahoo.comVERU Mar 2024 0.500 callMarch 9, 2024 | finance.yahoo.comVERU Mar 2024 3.000 putMarch 1, 2024 | finance.yahoo.comVERU Mar 2024 2.500 putFebruary 28, 2024 | msn.comVeru gets Nasdaq notice related to delayed quarterly report on form 10-Q Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address The only AI company to buy (Ad)The AI boom is just getting started. And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. VERU Media Mentions By Week VERU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. VERU News Sentiment▼0.660.79▲Average Medical News Sentiment VERU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. VERU Articles This Week▼92▲VERU Articles Average Week Get Veru News Delivered to You Automatically Sign up to receive the latest news and ratings for VERU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: XERS News NUS News NATR News MED News EL News IPAR News PBH News HLF News USNA News GHRS News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:VERU) was last updated on 5/29/2024 by MarketBeat.com Staff From Our PartnersShocking $16T Elon Musk Crypto LeakCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarThe #1 Crypto for AIWeiss RatingsDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro4 Cryptos BETTER than BitcoinTrue Market InsidersBill Gates is all about this tiny $2 stockTimothy SykesForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Veru Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.